|Day Low/High||1.20 / 1.25|
|52 Wk Low/High||1.03 / 3.30|
Results to Form Part of Planned Applications for Marketing Approvals in EU and US
Industry Veteran Brings Over 25 Years of Pharmaceutical and Drug Development Experience
Incremental Risk of Elevated IOP Relative to Control Decreases Through Last Follow-up Visit
Data Presented at 2016 Annual Meeting & Exposition of the Controlled Release Society
Plan to Facilitate Product Development and Reduce Operating Expenses
Study Results Showing No Recurrence of Disease and Statistically Significant Improvement in Visual Acuity to be Published in Ophthalmology
Promising Results for Potential Sustained Treatment of Wet AMD Using a TKI
Trade-Ideas LLC identified pSivida (PSDV) as a weak on high relative volume candidate
Trade-Ideas LLC identified pSivida (PSDV) as a strong on high relative volume candidate
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABBV, ACHN, DBD, DFS, GBLI, IFON, JOBS, LCUT, LOJN, NTL, RAIL, STT, TTWO, UVV Downgrades: AAWW, ASPN, BCH, ECPG, ETE, GSL, LPG, LXU, MW, MYRG, NTK, PCYO, PSDV, SEB, TNGO Initiations: RWLK, TPH, VTAE Read on to get TheStreet Quant Ratings' detailed report:
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, announced that the Company now plans to file a New Drug Application (NDA) for Medidur...
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that Dr.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.